Filing Details
- Accession Number:
- 0001179110-13-017174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-27 15:39:52
- Reporting Period:
- 2013-11-25
- Filing Date:
- 2013-11-27
- Accepted Time:
- 2013-11-27 15:39:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204787 | Clive Meanwell | 8 Sylvan Way Parsippany NJ 07054 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-25 | 10,000 | $36.71 | 317,773 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-25 | 99,864 | $28.01 | 417,637 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-25 | 99,864 | $36.71 | 317,773 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-26 | 25,136 | $28.01 | 342,909 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-26 | 25,136 | $36.66 | 317,773 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right-to-buy) | Disposition | 2013-11-25 | 99,864 | $0.00 | 99,864 | $28.01 |
| Common Stock | Option (Right-to-buy) | Disposition | 2013-11-26 | 25,136 | $0.00 | 25,136 | $28.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,136 | 2013-12-23 | No | 4 | M | Direct | |
| 0 | 2013-12-23 | No | 4 | M | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell on October 25, 2013.
- The range of prices for the transactions reported on this line is between $36.37 and $36.84 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price.
- As of November 25, 2013, the original grant (125,000 shares granted on December 23, 2003) was fully vested.
Billionaire Hedge Funds
